EUVIMEDEUVIMED entdecken
Crossref

Development of Curcumin-Loaded Polymeric Nanoparticles for Targeted Therapy in Alzheimer’s Disease

Faisal Mamdouh Alhajri, Chaya. M, Sreeharsha Nagaraja, Afzal Haq Asif, Veeriah Chowdary Jasthi, Sulochana. S. A

International Journal of Drug Delivery Technology · 31.03.2026 · 16 (3s)

DOI: 10.25258/ijddt.16.3s.126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 31.03.2026. Verfasst von Faisal Mamdouh Alhajri und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a chronic neurodegenerative condition that manifests itself in the form of cognitive dysfunction, memory loss, oxidative stress, and deposition of amyloid-β plaque within the brain. Curcumin, a naturally existing polyphenolic substance obtained from Curcuma longa, has proven to be effective in terms of neuroprotection, antioxidant activity, anti-inflammatory as well as anti-amyloid actions. Nonetheless, its clinical use is restrained by low aqueous solubility, fast metabolism, marginal systemic bioavailability and limited ability to penetrate the blood–brain barrier. To this end, the present study was aimed to design curcumin-loaded polymeric nanoparticles for effective delivery and sustained release of the final drug to be ultimately used as a therapeutic tool against Alzheimer’s disease. Polymeric nanoparticles were prepared by a nanoprecipitation method using poly(lactic-co-glycolic acid) (PLGA) as biodegradable polymer and polyvinyl alcohol (PVA) as stabilizing agent. Eight formulations were developed by changing polymer and surfactant concentrations. The synthesized nanoparticles were thoroughly characterized for particle size, polydispersity index, zeta potential, drug loading & entrapment efficiency, structural compatibility (FTIR), thermal behavior (DSC), crystallinity (XRD), morphology (SEM and TEM), in vitro drug release, antioxidant activity mucoadhesion potential and stability. The optimized formulation had nanoscale particle size (165 nm), narrow size distribution and high entrapment efficiency (82%). Structural and thermal analyses evidenced encapsulation of curcumin inside the polymeric matrix in amorphous state. In vitro release studies showed that the drug was released in a biphasic manner according to Higuchi diffusion kinetics with sustained release for up to 48 hours. The nanoparticle formulation also exhibited improved antioxidant activity compared to free curcumin and provided sufficient physicochemical stability in the storage condition. The results suggest that the latter will be a potential nano therapeutic strategy for enhancing drug delivery and therapeutic efficacy for management of Alzheimer's disease through curcumin loaded polymeric nanoparticles.

Zitieren

APA

Alhajri, F. M., M, C., Nagaraja, S., Asif, A. H., Jasthi, V. C., & A, S. S. (2026). Development of Curcumin-Loaded Polymeric Nanoparticles for Targeted Therapy in Alzheimer’s Disease. International Journal of Drug Delivery Technology, 16(3s). https://doi.org/10.25258/ijddt.16.3s.126

Vancouver

Alhajri FM, M C, Nagaraja S, Asif AH, Jasthi VC, A SS. Development of Curcumin-Loaded Polymeric Nanoparticles for Targeted Therapy in Alzheimer’s Disease. International Journal of Drug Delivery Technology. 2026;16(3s). doi:10.25258/ijddt.16.3s.126

BibTeX
@article{Alhajri2026,
  author = {Alhajri, Faisal Mamdouh and M, Chaya. and Nagaraja, Sreeharsha and Asif, Afzal Haq and Jasthi, Veeriah Chowdary and A, Sulochana. S.},
  title = {Development of Curcumin-Loaded Polymeric Nanoparticles for Targeted Therapy in Alzheimer’s Disease},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {3s},
  doi = {10.25258/ijddt.16.3s.126}
}
Kostenlos starten →